Clinical trial
ArcticLine Feasibility Study
NCT03604263 is registered in ClinicalTrials.gov with Medtronic Cardiac Ablation Solutions as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ArcticLine Feasibility Study
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 18, 2018
- Completion date
- November 18, 2019
- Enrollment
- 17 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.